EBMT 2020 | Challenges associated with implementing MSCs into routine practice

Francesco Dazzi, MD, PhD, King’s College Hospital NHS Foundation Trust, London, UK, outlines some of the challenges associated with implementing mesenchymal stem cells (MSCs) into treatment strategies and discusses the exploitation of apoptotic cells in order to generate the necessary regeneration signals. This interview was recorded via an online conference call with The Video Journal of Regenerative Medicine (VJRegenMed).